机构:[1]Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, People’s Republic of China[2]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, People’s Republic of China[3]Medical Oncology, The First People’s Hospital of Yunnan Province, Kunming, People’s Republic of China内科片肿瘤内科云南省第一人民医院[4]Surgical Oncology, The First People’s Hospital of Yunnan Province Kunming, People’s Republic of China内科片肿瘤内科云南省第一人民医院[5]Institute of Clinical and Basic Medicine Research, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People’s Republic of China云南省第一人民医院
Objective: This study investigated clinical and pathological characteristics and risk factors in papillary thyroid carcinoma (PTC) patients' native to Yunnan plateau in southwestern China. Methods: Clinical data from 1,198 patients diagnosed with PTC (n=578) and control subjects (n=620) with benign thyroid disease (ie, thyroid nodule disease, benign thyroid diseases [BTD]) in Yunnan province were analyzed retrospectively. Results: The mean patient age was lower for PTC than for BTD. Positive ratios of thyroid peroxidase antibody, thyroglobulin antibody (TGAb), and thyrotrophin receptor antibody (TRAb) were higher in PTC than in BTD patients. The ratio of PTC coexisting with Hashimoto's thyroiditis (HT) or with lymphocytic thyroiditis was higher than that of BTD. The number of patients whose age at menarche was <= 13 years, who had given birth to less than or equal to two children, or who were in premenopause were higher in the PTC than in the BTD group. Multivariate conditional logistic regression analyses revealed that age >45 years, nodal size >1 cm, and elevated TG levels were protective factors against PTC. Abnormally elevated TGAb and TRAb levels were independent risk factors for PTC in females. Conclusion: HT was not an independent risk factor for but was associated with PTC. TRAb is a risk factor for PTC in individuals living in the Yunnan plateau, but not for those in the plains region.
基金:
This study was sponsored by grants from the Health Bureau of Yunnan Province (D-201203), the Science Technology Department of Yunnan Province (2013HB084), and the First People’s Hospital of Yunnan Province Institute of Basic Medical Internal Institutions Project (2014N269).
第一作者机构:[1]Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, People’s Republic of China[2]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, People’s Republic of China[3]Medical Oncology, The First People’s Hospital of Yunnan Province, Kunming, People’s Republic of China
通讯作者:
通讯机构:[5]Institute of Clinical and Basic Medicine Research, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People’s Republic of China[*1]Institute of Clinical and Basic Medicine Research, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, People’s Republic of China
推荐引用方式(GB/T 7714):
Zeng Rong,Shou Tao,Yang Kun-xian,et al.Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China[J].THERAPEUTICS AND CLINICAL RISK MANAGEMENT.2016,12:1065-1074.doi:10.2147/TCRM.S105023.
APA:
Zeng, Rong,Shou, Tao,Yang, Kun-xian,Shen, Tao,Zhang, Jin-ping...&Yan, Xin-ming.(2016).Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China.THERAPEUTICS AND CLINICAL RISK MANAGEMENT,12,
MLA:
Zeng, Rong,et al."Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China".THERAPEUTICS AND CLINICAL RISK MANAGEMENT 12.(2016):1065-1074